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UDRI technology to quickly
diagnose COVID-19 licensed
Software developed by a University of Dayton Research
Institute scientist to quickly diagnose COVID-19 has been
exclusively licensed by Greenville, South Carolina, software
development company Blue Eye Soft. The technology, which
detected the presence of the COVID-19 disease on a dataset
of chest X-rays in seconds with 98 percent accuracy, was
adapted from existing medical diagnostic software in a
matter of hours, then licensed in less than three days. 
Blue Eye Soft owner Srikanth Kodeboyina — an alumnus of
UD — and his team further developed the technology, and
he plans to submit a full proposal to the FDA for approval
within a matter of days. The company has already  led a
provisional patent on the software.
"We hope to be able to bring this new tool to market very
quickly," Kodeboyina said, adding that his start-up
company's sta  of 40 employees has been virtually joined in
the last several days by more than 100 professionals based
in Singapore, India and across the U.S., all contributing their
expertise in arti cial intelligence, medical licensing,
cybersecurity and other related  elds, to help expedite the
development of the product.
The software, developed by UDRI research scientist Barath
Narayanan, uses a "deep learning" algorithm that searches
for markings on X-rays that indicate the presence of COVID-
19. Narayanan, who spends his days working on sponsored
research programs in arti cial intelligence for manufacturing
and other commercial applications, has for several years
been working evenings and weekends pursuing his principal
passion: advancing research in AI to help doctors diagnose
and treat patients more quickly. 
Using medical imaging including X-rays, CT scans, blood
smear slides and eye scans, Narayanan had already
developed a number of software codes that successfully
detect—with 92 to 99 percent accuracy—lung and breast
cancers, malaria, brain tumors, tuberculosis, diabetic
retinopathy and pneumonia. When a set of chest X-rays
from patients with and without COVID-19 were recently
made available, Narayanan quickly switched focus to
develop coding to detect the disease on the images. Drawing
on expertise developed on and o  the clock, he quickly
developed an algorithm that classi ed the images as having,
or not having, COVID-19 with a high degree of accuracy.
Narayanan, who received his master's and doctoral degrees
in electrical engineering from UD, said he enjoyed the image
processing aspect of his graduate student research, and
decided to use the  eld to help people in some way. 
"I wanted to do something for the common good, and
medical imaging seemed a good way to do that," he said.
"Software-based diagnostic tools can serve as a valuable,
virtual second opinion for medical professionals, especially
in parts of the world where medical teams are short-
sta ed. With additional research, these technologies can be
 ne-tuned to detect even the slightest anomalies on images
—those that are di cult to see with the human eye—
helping doctors diagnose and treat patients more quickly." 
Kodeboyina, who received his master's degree in electrical
and computer engineering from UD in 2011, has also been on
a mission to develop software that will enhance human life,
he said. 
"I launched Blue Eye Soft in 2017 with a mission to create
job opportunities in areas that are innovative and impactful,"
he said. "Right now one of the most pressing needs on the
planet is addressing the COVID-19 crisis. Arti cial
intelligence can be an important solution to support the
healthcare industry in its  ght to mitigate the impact of the
disease, and we are on the leading edge of developing that
technology."
BES brought in a third-party company to validate its new
diagnostic system, and a number of customers in the public
and private sectors are already prepared to adopt the
technology once it has received FDA approval, Kodeboyina
Careers
said. In the United States, end-users will include hospitals,
laboratories and medical professionals, he added.
UD vice president for research John Leland said the
University has been working to execute technology licenses
quickly, but completing an agreement between UD and BES
in only two and a half days was unprecedented. 
"We were driven to help Blue Eye Soft make this technology
available as quickly as possible," Leland said. "We are also
excited that a UD grad has licensed one of our technologies
and is working diligently to provide medical professionals a
new tool in the  ght against the spread of this devastating
disease." 
While Narayanan is hoping to  nd funding that will enable
him to further develop AI tools for the medical  eld, he said
he will continue to work on his own time to help bring them
to the healthcare industry. He credits his graduate advisor
Russell Hardie, professor of electrical and computer
engineering in the University's School of Engineering, with
ongoing guidance and support in his o -hours pursuits. 
For media interviews, contact Pamela Gregg at 937-229-
3268 or pamela.gregg@udri.udayton.edu, and Blue Eye Soft
at info@blueyesoft.com or 864-479-0888.
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